Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FLRNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,499
Award facts
- Contract value 100% obligated
- $41,498.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,498.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/ml SureClick auto-injectors, with an ultimate completion date of September 29, 2025. This non-competitive, non-set-aside delivery order was issued on September 26, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, a $999,999,999.00 comprehensive global pharmaceutical supply agreement running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime vendor under the DLA pharmaceutical supply program, the company supplies a broad range of medications and medical devices across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and auto-injectors. Enbrel, a biologic immunosuppressant used primarily to treat rheumatoid arthritis and other autoimmune conditions, is a key specialty pharmaceutical product within the company's federal healthcare supply portfolio supporting Defense Health Agency operations and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FLRNN?
SPE2DB25FLRNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FLRNN worth?
The government has obligated $41,499 on SPE2DB25FLRNN.
Is contract SPE2DB25FLRNN an order under another contract?
Yes. SPE2DB25FLRNN is a delivery order under SPE2DB25D3002, an indefinite delivery contract.
Was contract SPE2DB25FLRNN competed?
The extent of competition for SPE2DB25FLRNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award